One case showed a different major genetic alteration (KRAS mutation) since day 0, which was probably due to the heterogeneity of the parental tumour causing sampling bias, although we were unable to trace back the genetic alteration in the patient matched-parental tumour or lymph node metastasis. Here, KRAS is linked to neoplasm.